Association between opioid use during mechanical ventilation in preterm infants and evidence of brain injury: a propensity score-matched cohort study.

Infant Mechanical ventilation Neurodevelopment Opioid Preterm

Journal

EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 04 08 2023
revised: 09 10 2023
accepted: 12 10 2023
medline: 13 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: epublish

Résumé

Preterm infants often require mechanical ventilation (MV), which can be a painful experience. Opioids (such as morphine) are used to provide analgesia, despite conflicting evidence about their impact on the developing brain. We aimed to quantify the use of opioids during MV in infants born at <32 weeks' gestational age and to investigate the association between opioid use and evidence of brain injury. In this retrospective propensity score-matched cohort study, we used routinely recorded data from the National Neonatal Research Database to study infants born at 22-31 weeks gestational age who were admitted to neonatal units in England and Wales (between Jan 1, 2012, and Dec 31, 2020) and who were mechanically ventilated on one or more days during their hospital stay. We used propensity score matching to identify pairs of infants (one who received opioids during MV and one who did not) with similar demographic and clinical characteristics. The pre-specified primary outcome was preterm brain injury assessed in all infants who received MV for more than two days and had evidence of preterm brain injury at or before discharge from neonatal care. Adjusted analyses accounted for differences in infants' characteristics, including illness severity and painful/surgical conditions. Of 67,206 infants included, 45,193 (67%) were mechanically ventilated for one or more days and 26,201 (58% of 45,193) received an opioid whilst ventilated. Opioids were given for a median of 67% of ventilated days (IQR 43-92%) and the median exposure was 4 days (2-11). The percentage of mechanically ventilated infants who received opioids while ventilated increased from 52% in 2012 to 60% in 2020 (morphine, 51%-56%; fentanyl, 6%-18%). In the propensity score-matched cohort of 3608 pairs who were ventilated for >2 consecutive days, the odds of any preterm brain injury (adjusted odds ratio 1.22, 95% CI 1.10-1.35) were higher in those who received opioids compared with those who did not (received opioids, 990/3608 (27.4%) vs. did not receive opioids, 855/3608 (23.7%). The adjusted odds of these adverse outcomes increased with increasing number of days of opioid exposure. Use of opioids during mechanical ventilation of preterm infants increased during the study period (2012-2020). Although causation cannot be determined, among those ventilated for >2 consecutive days, these data suggest that opioid use is associated with an increased risk of preterm brain injury and the risk increases with longer durations of exposure. University of Nottingham Impact Fund.

Sections du résumé

Background UNASSIGNED
Preterm infants often require mechanical ventilation (MV), which can be a painful experience. Opioids (such as morphine) are used to provide analgesia, despite conflicting evidence about their impact on the developing brain. We aimed to quantify the use of opioids during MV in infants born at <32 weeks' gestational age and to investigate the association between opioid use and evidence of brain injury.
Methods UNASSIGNED
In this retrospective propensity score-matched cohort study, we used routinely recorded data from the National Neonatal Research Database to study infants born at 22-31 weeks gestational age who were admitted to neonatal units in England and Wales (between Jan 1, 2012, and Dec 31, 2020) and who were mechanically ventilated on one or more days during their hospital stay. We used propensity score matching to identify pairs of infants (one who received opioids during MV and one who did not) with similar demographic and clinical characteristics. The pre-specified primary outcome was preterm brain injury assessed in all infants who received MV for more than two days and had evidence of preterm brain injury at or before discharge from neonatal care. Adjusted analyses accounted for differences in infants' characteristics, including illness severity and painful/surgical conditions.
Findings UNASSIGNED
Of 67,206 infants included, 45,193 (67%) were mechanically ventilated for one or more days and 26,201 (58% of 45,193) received an opioid whilst ventilated. Opioids were given for a median of 67% of ventilated days (IQR 43-92%) and the median exposure was 4 days (2-11). The percentage of mechanically ventilated infants who received opioids while ventilated increased from 52% in 2012 to 60% in 2020 (morphine, 51%-56%; fentanyl, 6%-18%). In the propensity score-matched cohort of 3608 pairs who were ventilated for >2 consecutive days, the odds of any preterm brain injury (adjusted odds ratio 1.22, 95% CI 1.10-1.35) were higher in those who received opioids compared with those who did not (received opioids, 990/3608 (27.4%) vs. did not receive opioids, 855/3608 (23.7%). The adjusted odds of these adverse outcomes increased with increasing number of days of opioid exposure.
Interpretation UNASSIGNED
Use of opioids during mechanical ventilation of preterm infants increased during the study period (2012-2020). Although causation cannot be determined, among those ventilated for >2 consecutive days, these data suggest that opioid use is associated with an increased risk of preterm brain injury and the risk increases with longer durations of exposure.
Funding UNASSIGNED
University of Nottingham Impact Fund.

Identifiants

pubmed: 37954903
doi: 10.1016/j.eclinm.2023.102296
pii: S2589-5370(23)00473-X
pmc: PMC10632414
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102296

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

We declare no competing interests.

Références

JAMA Netw Open. 2021 Jul 1;4(7):e2115998
pubmed: 34232302
Ann Pharmacother. 2015 Dec;49(12):1291-7
pubmed: 26369570
Arch Dis Child Fetal Neonatal Ed. 2022 Mar;107(2):150-155
pubmed: 34413093
JAMA. 2003 Nov 12;290(18):2419-27
pubmed: 14612478
Pediatr Res. 2020 Aug;88(2):168-175
pubmed: 31896130
JAMA. 2013 Jan 9;309(2):149-54
pubmed: 23299606
Lancet. 2004 May 22;363(9422):1673-82
pubmed: 15158628
Pediatrics. 2005 Aug;116(2):352-9
pubmed: 16061589
Eur J Pain. 2014 Jul;18(6):844-52
pubmed: 24318537
Pediatrics. 2016 Feb;137(2):e20154271
pubmed: 26810788
J Pediatr. 2016 May;172:7-8
pubmed: 26896158
Neonatology. 2016;110(3):190-7
pubmed: 27198526
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Lancet Child Adolesc Health. 2020 Apr;4(4):299-311
pubmed: 32119841
J Pediatr. 2017 Jan;180:99-104.e1
pubmed: 27522446
Clin Pharmacokinet. 2014 Jun;53(6):553-63
pubmed: 24496960
Eur J Clin Pharmacol. 2022 Apr;78(4):669-677
pubmed: 35028673
Pediatr Res. 2021 Feb;89(3):540-548
pubmed: 32454516
Acta Paediatr. 2019 Feb;108(2):208-217
pubmed: 30290021
EBioMedicine. 2019 Feb;40:655-662
pubmed: 30709768
Arch Dis Child Fetal Neonatal Ed. 2008 Sep;93(5):F362-7
pubmed: 18089630
Am J Epidemiol. 2019 Jan 1;188(1):250-257
pubmed: 30189042
BMJ Paediatr Open. 2022 May;6(1):
pubmed: 36053596
Pediatr Res. 2023 Aug;94(2):738-746
pubmed: 36859445
Cochrane Database Syst Rev. 2021 Mar 17;3:CD013732
pubmed: 33729556
Lancet Respir Med. 2015 Oct;3(10):796-812
pubmed: 26420017
Arch Dis Child Fetal Neonatal Ed. 2020 Jul;105(4):425-431
pubmed: 31732683
Pain. 2013 Mar;154(3):449-458
pubmed: 23352760

Auteurs

Lisa Szatkowski (L)

Centre for Perinatal Research, Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.

Don Sharkey (D)

Centre for Perinatal Research, Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.

Helen Budge (H)

Centre for Perinatal Research, Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.

Shalini Ojha (S)

Centre for Perinatal Research, Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
Neonatal Unit, University Hospitals of Derby and Burton NHS Trust, Derby, UK.

Classifications MeSH